Glutamate Chemical Exchange Saturation Transfer (GluCEST) Magnetic Resonance Imaging in Pre-clinical and Clinical Applications for Encephalitis.
Staphylococcus aureus
chemical exchange saturation transfer
encephalitis
glutamate
magnetic resonance imaging
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2020
2020
Historique:
received:
07
03
2020
accepted:
25
06
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
28
8
2020
Statut:
epublish
Résumé
Encephalitis is a common central nervous system inflammatory disease that seriously endangers human health owing to the lack of effective diagnostic methods, which leads to a high rate of misdiagnosis and mortality. Glutamate is implicated closely in microglial activation, and activated microglia are key players in encephalitis. Hence, using glutamate chemical exchange saturation transfer (GluCEST) imaging for the early diagnosis of encephalitis holds promise. The sensitivity of GluCEST imaging with different concentrations of glutamate and other major metabolites in the brain was validated in phantoms. Twenty-seven Sprague-Dawley (SD) rats with encephalitis induced by The number of amine protons on glutamate that had a chemical shift of 3.0 ppm away from bulk water and the signal intensity of GluCEST were concentration-dependent. Under physiological conditions, glutamate is the main contributor to the GluCEST signal. Compared with normal tissue, in both rats and patients with encephalitis, the encephalitis areas demonstrated a hyper-intense GluCEST signal, while the lacunar infarction had a decreased GluCEST signal intensity. After intravenous immunoglobulin therapy, patients with encephalitis lesions showed a decrease in GluCEST signal, and the results were significantly different from the pre-treatment signal (1.34 ± 0.31 vs 5.0 ± 0.27%, respectively; Glutamate plays a role in encephalitis, and the GluCEST imaging signal has potential as an
Sections du résumé
BACKGROUND
BACKGROUND
Encephalitis is a common central nervous system inflammatory disease that seriously endangers human health owing to the lack of effective diagnostic methods, which leads to a high rate of misdiagnosis and mortality. Glutamate is implicated closely in microglial activation, and activated microglia are key players in encephalitis. Hence, using glutamate chemical exchange saturation transfer (GluCEST) imaging for the early diagnosis of encephalitis holds promise.
METHODS
METHODS
The sensitivity of GluCEST imaging with different concentrations of glutamate and other major metabolites in the brain was validated in phantoms. Twenty-seven Sprague-Dawley (SD) rats with encephalitis induced by
RESULTS
RESULTS
The number of amine protons on glutamate that had a chemical shift of 3.0 ppm away from bulk water and the signal intensity of GluCEST were concentration-dependent. Under physiological conditions, glutamate is the main contributor to the GluCEST signal. Compared with normal tissue, in both rats and patients with encephalitis, the encephalitis areas demonstrated a hyper-intense GluCEST signal, while the lacunar infarction had a decreased GluCEST signal intensity. After intravenous immunoglobulin therapy, patients with encephalitis lesions showed a decrease in GluCEST signal, and the results were significantly different from the pre-treatment signal (1.34 ± 0.31 vs 5.0 ± 0.27%, respectively;
CONCLUSION
CONCLUSIONS
Glutamate plays a role in encephalitis, and the GluCEST imaging signal has potential as an
Identifiants
pubmed: 32848546
doi: 10.3389/fnins.2020.00750
pmc: PMC7399024
doi:
Types de publication
Journal Article
Langues
eng
Pagination
750Informations de copyright
Copyright © 2020 Jia, Chen, Geng, Cheng, Li, Qiu, Huang, Wang, Zhang and Wu.
Références
J Clin Neurol. 2016 Jan;12(1):1-13
pubmed: 26754777
NMR Biomed. 2018 Feb;31(2):
pubmed: 29193448
Biol Psychiatry. 2020 Feb 1;87(3):225-233
pubmed: 31521336
Quant Imaging Med Surg. 2019 Oct;9(10):1652-1663
pubmed: 31728309
NMR Biomed. 2015 May;28(5):555-65
pubmed: 25807919
Neuroradiology. 2019 Aug;61(8):853-860
pubmed: 31028423
Mol Psychiatry. 2017 Sep;22(9):1298-1305
pubmed: 28115738
J Nanobiotechnology. 2019 Dec 17;17(1):123
pubmed: 31847857
Magn Reson Med. 2018 Nov;80(5):2033-2039
pubmed: 29802635
Neurobiol Dis. 2016 Oct;94:116-28
pubmed: 27326668
Biometals. 2016 Jun;29(3):365-76
pubmed: 27053146
Magn Reson Med. 2008 Mar;59(3):475-84
pubmed: 18306400
Front Neurosci. 2018 Mar 22;12:189
pubmed: 29623027
Neuroimage. 2020 Jan 1;204:116245
pubmed: 31605825
Magn Reson Med. 2018 Aug;80(2):662-671
pubmed: 29577382
Neuroimage Clin. 2019;22:101694
pubmed: 30822716
J Neurochem. 2016 Nov;139(3):432-439
pubmed: 27529288
Neuroimage. 2013 Aug 15;77:262-7
pubmed: 23583425
Nat Med. 2012 Jan 22;18(2):302-6
pubmed: 22270722
NMR Biomed. 2017 Jul;30(7):
pubmed: 28272785
J Magn Reson Imaging. 2019 Dec;50(6):1866-1872
pubmed: 31033089
ACS Chem Neurosci. 2019 Aug 21;10(8):3859-3867
pubmed: 31343167
Sci Transl Med. 2015 Oct 14;7(309):309ra161
pubmed: 26468323
Sci Rep. 2018 Feb 13;8(1):2883
pubmed: 29440753
Clin Infect Dis. 2013 Oct;57(8):1114-28
pubmed: 23861361
J Nippon Med Sch. 2017;84(4):160-164
pubmed: 28978895
Infection. 2019 Apr;47(2):267-273
pubmed: 30506479
Magn Reson Med. 2013 Dec;70(6):1690-8
pubmed: 24123389
Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):407-420
pubmed: 30291374
Front Neurosci. 2017 Aug 31;11:489
pubmed: 28912676
Neurol Sci. 2019 Aug;40(8):1567-1575
pubmed: 30955116
J Neuroinflammation. 2012 Dec 23;9:275
pubmed: 23259598
Neuroimage. 2014 Nov 1;101:185-92
pubmed: 25003815
No To Hattatsu. 2017 Jan;49(1):46-50
pubmed: 30011155
Magn Reson Med. 2005 Sep;54(3):507-12
pubmed: 16086319
Eur J Neurosci. 2020 Feb;51(4):984-990
pubmed: 31585485
J Neurosci Res. 2014 Dec;92(12):1792-800
pubmed: 25043715
J Magn Reson. 2000 Mar;143(1):79-87
pubmed: 10698648
Lancet Infect Dis. 2010 Dec;10(12):835-44
pubmed: 20952256
J Cereb Blood Flow Metab. 2015 Jun;35(6):917-21
pubmed: 25833344
ACS Chem Neurosci. 2019 Jan 16;10(1):649-657
pubmed: 30346712
F1000Res. 2020 Jan 29;9:
pubmed: 32047620